Filing Flows › Jupiter Neurosciences (JUNS) › Q2 2026 › vs Q1 2026
Jupiter Neurosciences (JUNS) Q2 2026 vs Q1 2026 (quarter over quarter)
Jupiter Neurosciences's revenue rose $6K (+30%) from $19K in Q1 2026 to $24K in Q2 2026.
Jupiter Neurosciences, Q2 2026: revenue $24K, net loss $2.3M, operating cash flow −$2.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $24K | $19K | $6K | +30% |
| Other income, net | $469K | −$99K | $568K | — |
| Net loss | $2.3M | $2.1M | $212K | +10% |
| Costs & expenses | $2.8M | $2.1M | $687K | +33% |
| Operating costs | $2.8M | $2.0M | $786K | +40% |
| Cost of revenue | $3K | $4K | −$1K | -27% |
| Research & development | $600K | $411K | $189K | +46% |
| SG&A | $2.2M | $1.6M | $597K | +38% |
| Operating cash sources | $2.8M | $1.9M | $853K | +44% |
| Share-based compensation | $491K | $501K | −$10K | -2% |
| Cash used in operations | $2.3M | $1.4M | $863K | +60% |
| Net loss absorbed | $2.3M | $2.1M | $212K | +10% |
| Working capital & other | $512K | −$129K | $640K | — |
Questions
How much did Jupiter Neurosciences's revenue grow quarter over quarter in Q2 2026?
Jupiter Neurosciences's revenue rose $6K (+30%) from $19K in Q1 2026 to $24K in Q2 2026.